1. Home
  2. GMEX vs VRAX Comparison

GMEX vs VRAX Comparison

Compare GMEX & VRAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GMEX

GMEX ROBOTICS CORPORATION Class A Ordinary Shares

N/A

Current Price

$0.79

Market Cap

1.7M

ML Signal

N/A

Logo Virax Biolabs Group Limited

VRAX

Virax Biolabs Group Limited

HOLD

Current Price

$0.18

Market Cap

1.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GMEX
VRAX
Founded
2005
2013
Country
Australia
United Kingdom
Employees
16
N/A
Industry
Recreational Games/Products/Toys
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.7M
1.6M
IPO Year
2023
2021

Fundamental Metrics

Financial Performance
Metric
GMEX
VRAX
Price
$0.79
$0.18
Analyst Decision
Strong Buy
Analyst Count
0
1
Target Price
N/A
$1.00
AVG Volume (30 Days)
1.8M
31.8M
Earning Date
04-17-2026
06-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$217,274.83
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.24
$0.10
52 Week High
$2.50
$1.14

Technical Indicators

Market Signals
Indicator
GMEX
VRAX
Relative Strength Index (RSI) 34.77 45.91
Support Level $0.35 $0.11
Resistance Level $1.25 $0.18
Average True Range (ATR) 0.27 0.03
MACD -0.11 -0.01
Stochastic Oscillator 3.96 8.94

Price Performance

Historical Comparison
GMEX
VRAX

About GMEX GMEX ROBOTICS CORPORATION Class A Ordinary Shares

GMEX Robotics Corp is engaged in the design and deployment of AI-powered robotics and intelligent consumer technologies. The group operates in three business areas: Consumer and Commercial Robotics: Developing intuitive and interactive robots designed to assist with daily tasks, provide smart home integration, and offer new levels of convenience and connectivity to boost productivity; AI-Driven Hardware: Embedding artificial intelligence into physical products to create self-learning and adaptive user experiences; and Innovation & Ecosystem: Building a robust ecosystem of robotic products that communicate and evolve, powered by proprietary AI algorithms.

About VRAX Virax Biolabs Group Limited

Virax Biolabs Group Ltd is an inventive biotechnology company focused on the detection of immune responses to and diagnosis of viral diseases. Through its ViraxImmune platform and ImmuneSelect portfolio of research-use-only (RUO) products and services, the Company is building an immune-profiling offering that spans RUO assays, preclinical immunology services and, longer term, T cell-based diagnostics aimed at post-acute infection syndromes (PAIS) such as Long COVID and other chronic conditions linked to immune dysregulation.

Share on Social Networks: